Literature DB >> 28268171

Diastolic dysfunction in hypertension.

R Nazário Leão1, P Marques da Silva2.   

Abstract

Hypertension and coronary heart disease, often coexisting, are the most common risk factors for heart failure. The progression of hypertensive heart disease involves myocardial fibrosis and alterations in the left ventricular geometry that precede the functional change, initially asymptomatic. The left ventricular diastolic dysfunction is part of this continuum being defined by the presence of left ventricular diastolic dysfunction without signs or symptoms of heart failure or poor left ventricular systolic function. It is highly prevalent in hypertensive patients and is associated with increased cardiovascular morbidity and mortality. Despite its growing importance in clinical practice it remains poorly understood. This review aims to present the epidemiological fundamentals and the latest developments in the pathophysiology, diagnosis and treatment of left ventricular diastolic dysfunction.
Copyright © 2017 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diastolic dysfunction; Disfunción diastólica; Enfermedad cardíaca hipertensiva; Geometría ventricular izquierda; Heart failure with preserved ejection fraction; Hipertensión; Hypertension; Hypertensive heart disease; Insuficiencia cardíaca con fracción de eyección preservada; Left Ventricular geometry

Year:  2017        PMID: 28268171     DOI: 10.1016/j.hipert.2017.01.001

Source DB:  PubMed          Journal:  Hipertens Riesgo Vasc        ISSN: 1889-1837


  4 in total

1.  Cardioprotective effect of silicon-built restraint device (ASD), for left ventricular remodeling in rat heart failure model.

Authors:  Waqas Nawaz; Muhammad Naveed; Jing Zhang; Sobia Noreen; Muhammad Saeed; Kiganda Raymond Sembatya; Awais Ullah Ihsan; Imran Shair Mohammad; Gang Wang; Xiaohui Zhou
Journal:  J Mater Sci Mater Med       Date:  2022-05-10       Impact factor: 4.727

2.  Systolic time ratio measured by impedance cardiography accurately screens left ventricular diastolic dysfunction in patients with arterial hypertension.

Authors:  Rodrigo Nazário Leão; Pedro Marques Silva; Luísa Branco; Helena Fonseca; Bruno Bento; Marta Alves; Daniel Virella; Roberto Palma Reis
Journal:  Clin Hypertens       Date:  2017-12-27

3.  Efficacy evaluation of serum galectin-3 in hypertension complicated with diastolic dysfunction.

Authors:  Tianwei Dong; Hongbin Li; Shuang Wang; Weida Chen
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

4.  Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction-Subanalysis of the TELEREH-HF Randomized Clinical Trial.

Authors:  Robert Irzmański; Renata Glowczynska; Maciej Banach; Dominika Szalewska; Ryszard Piotrowicz; Ilona Kowalik; Michael J Pencina; Wojciech Zareba; Piotr Orzechowski; Slawomir Pluta; Zbigniew Kalarus; Grzegorz Opolski; Ewa Piotrowicz
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.